How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Skin Absorption Patch Market
- By Patch Type: Microneedle Patch, Hydrogel Patch, Adhesive Patch, Polymer Patch, Electrochemical Patch
- By Application: Pain Management, Hormone Replacement Therapy, Nicotine Replacement Therapy, Vaccine Delivery, Cosmetic and Anti-aging
- By Drug Type: Small Molecule Drugs, Biologics, Peptides, Vaccines, Hormones
- By End User: Hospitals, Clinics, Home Care Settings, Pharmacies, Research Laboratories
- By Technology: Iontophoresis, Sonophoresis, Microneedle Technology, Chemical Enhancers, Electroporation
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Microneedle Patch leads By Patch Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 307 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Skin Absorption Patch Market report
A complete, evidence-based study - 12 chapters and 129 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Patch Type 5
Application 5
Drug Type 5
End User 5
Technology 5
Companies profiled
3M Company
Medi-Tate Inc.
Zosano Pharma Corporation
MediWound Ltd.
Altea Therapeutics Inc.
BioDelivery Sciences International Inc.
Mylan N.V. (now part of Viatris)
Noven Pharmaceuticals Inc.
Hisamitsu Pharmaceutical Co. Inc.
LTS Lohmann Therapie-Systeme AG
Troy Corporation
Medi-Flex Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →3M Company
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medi-Tate Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Zosano Pharma Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →MediWound Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Altea Therapeutics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →BioDelivery Sciences International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Mylan N.V. (now part of Viatris)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Noven Pharmaceuticals Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hisamitsu Pharmaceutical Co. Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →LTS Lohmann Therapie-Systeme AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Troy Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Medi-Flex Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Cure Pharmaceutical Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →PharmaDerm Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →MediBeacon
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,427M by 2033 · 11.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Microneedle Patch29.6
- Hydrogel Patch23.9
- Adhesive Patch20.3
- Polymer Patch10.0
- Electrochemical Patch16.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,054M → $2,276M · 10.1%
Europe$734.6M → $1,832M · 12.1%
Asia Pacific$670.7M → $1,406M · 9.7%
Latin America$415.2M → $972.2M · 11.2%
Middle East and Africa$319.4M → $730.7M · 10.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.072026
11.092027
11.102028
11.112029
11.132030
11.142031
11.152032
11.152033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- 3M Company22.3
- Medi-Tate Inc.18.2
- Zosano Pharma Corporation8.0
- MediWound Ltd.4.6
- Altea Therapeutics Inc.10.3
- BioDelivery Sciences International Inc.8.4
- Others28.2
Segment contribution to growth (%)
Fig. 18 · p.39 →Patch Type13.2%
Application20.4%
Drug Type30.6%
End User25.8%
Technology9.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.5
- Europe25.4
- Asia Pacific19.5
- Latin America13.5
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| 3M Company | 90 | 84 | 82 | 77 | 74 | 92 | 83 |
| Medi-Tate Inc. | 75 | 69 | 86 | 77 | 83 | 92 | 80 |
| Zosano Pharma Corporation | 87 | 67 | 87 | 82 | 78 | 67 | 78 |
| MediWound Ltd. | 71 | 68 | 75 | 69 | 61 | 70 | 69 |
| Altea Therapeutics Inc. | 65 | 65 | 59 | 62 | 61 | 56 | 61 |
| BioDelivery Sciences International Inc. | 62 | 56 | 68 | 55 | 65 | 59 | 61 |
| Mylan N.V. (now part of Viatris) | 41 | 62 | 64 | 65 | 66 | 40 | 56 |
| Noven Pharmaceuticals Inc. | 59 | 43 | 58 | 47 | 41 | 50 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- 3M Company
- Medi-Tate Inc.
- Zosano Pharma Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| 3M Company | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Medi-Tate Inc. | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Zosano Pharma Corporation | ◐ | ✓ | ◐ | ✓ | ◐ | ◐ |
| MediWound Ltd. | ✓ | ◐ | ◐ | ◐ | − | ◐ |
| Altea Therapeutics Inc. | ✓ | ◐ | ◐ | ◐ | − | ◐ |
| BioDelivery Sciences International Inc. | ◐ | − | ✓ | − | ✓ | − |
| Mylan N.V. (now part of Viatris) | − | − | ◐ | ◐ | ◐ | − |
| Noven Pharmaceuticals Inc. | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →13M Company83
2Medi-Tate Inc.80
3Zosano Pharma Corporation78
4MediWound Ltd.69
5Altea Therapeutics Inc.61
6BioDelivery Sciences International Inc.61
7Mylan N.V. (now part of Viatris)56
8Noven Pharmaceuticals Inc.50
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
3M CompanyMedi-Tate Inc.Zosano Pharma Corporation
Challenger1
Strong scale, closing on the leaders.
MediWound Ltd.
Contender2
Focused players with pockets of strength.
Altea Therapeutics Inc.BioDelivery Sciences International Inc.
Niche2
Specialists in a single segment or region.
Mylan N.V. (now part of Viatris)Noven Pharmaceuticals Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Patch Type in North America, then scale across Skin Absorption Patch Market — a $674M beachhead inside a $9.09B market.
Beachhead (SOM)$674Mobtainable near-term
Serviceable (SAM)$3.80Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Microneedle Patch
Best fit — highest urgency & budget in Patch Type.
Economic buyer81 fit
Hydrogel Patch
Strong fit — clear ROI and a fast path to value.
End user66 fit
Adhesive Patch
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Patch Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Drug Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel30%
Digital / self-serve18%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Patch Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Skin Absorption Patch Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified23%
Evaluation14%
Closed-won8%
$19.2KCAC
$66KLTV
3.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Skin Absorption Patch Market is a resilient opportunity — $6.28B by 2033, compounding at 5.6%.
TAM · 2025$4.07Btoday
TAM · 2033$6.28Bforecast
CAGR5.6%2027–2033
Cumulative$45.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.28BTotal addressable market
SAM$2.20BServiceable available market
SOM$396MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.6% CAGR
Demand compounds through 2033, outpacing GDP across Patch Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Patch Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.28BLarge & growingTAM by 2033 at 5.6% CAGR
$2.20BServiceable nowreachable with today’s model
$396MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.90BBear3.6% CAGR
$6.28BBase5.6% CAGR
$8.04BBull7.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Skin Absorption Patch Market — a $4.33B market by 2033. Plan: grow share from 8.3% to 14.1%.
Market size · 2033$4.33Btotal addressable
Market CAGR3.5%2027–2033
Target share14.1%from 8.3% today
Revenue ambition$610Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.3% | 14.1% | Behind |
| Revenue | $324M | $610M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 36.2% | 43.4% | At risk |
| Customer retention | 85.0% | 95.9% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Patch Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Patch Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $77M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Patch Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Skin Absorption Patch Market conversation — a $4.07B market you can size, segment and defend in minutes.
Market size · 2033$4.07Btotal opportunity
Growth9.8%CAGR to 2033
Addressable buyers1,035+accounts in scope
Typical ROI6.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Patch Type
Goal Grow share in Patch Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.1×return on cost, year one
< 3 mopayback period
$96K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
3M CompanyMedi-Tate Inc.Zosano Pharma CorporationMediWound Ltd.Altea Therapeutics Inc.BioDelivery Sciences International Inc.Mylan N.V. (now part of Viatris)Noven Pharmaceuticals Inc.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Skin Absorption Patch Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Skin Absorption Patch Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Skeletal Muscular Relaxants Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportSkeletal Muscle Actin Monoclonal Antibody Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportSkeletal Muscle Actin Antibody Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportSkeletal Expansion Screws Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportSjogren's Syndrome Treatment Drugs Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportSjogren's Syndrome Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportSize Exclusion Chromatography (SEC) System Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportSize Exclusion Chromatography (SEC) HPLC Column Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportSize 312 Hearing Aid Batteries Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportSix-channel ECG Machine Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportSivelestat Sodium Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportSivelestat Sodium Hydrate API Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.